Literature DB >> 22915622

The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic.

Denis Poddubnyy1, Henning Brandt, Janis Vahldiek, Inge Spiller, In-Ho Song, Martin Rudwaleit, Joachim Sieper.   

Abstract

OBJECTIVE: This study was aimed at investigating the frequencies of non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS) diagnoses and their ratios in relation to symptom duration in patients referred because of chronic back pain and suspicion of axial SpA.
METHODS: In this monocentre study, orthopaedists and primary care physicians were requested to refer patients with chronic low back pain (duration >3 months) and onset of back pain before 45 years of age to a SpA-specialised rheumatology outpatient clinic for further diagnostic investigation, if proposed screening parameters were present. The ratio of nr-axSpA to AS was analysed in relation to the duration of symptoms.
RESULTS: A diagnosis of definite axial SpA was made in 43.7% of the referred patients (n=522). Axial SpA was diagnosed in a similar percentage of about 50% if back pain duration was <9 years but decreased to 36% if symptom duration was >9 years. Nr-axSpA represented the majority of patients (67.3%) only if duration of back pain was 1 year and less at the time of referral. Between 1 and 6 years of back pain duration the probability of nr-axSpA and AS was nearly equal (1-3 years: 52.5% and 47.5%, respectively; 3-6 years: 53.7% and 46.3%, respectively). In patients with back pain duration of 6-9 years, AS was more likely (61.1%) to be diagnosed than nr-axSpA (38.9%), and this increased further over time.
CONCLUSIONS: Non-radiographic axial SpA represents an important differential diagnosis of back pain, especially in patients with recent symptom onset.

Entities:  

Mesh:

Year:  2012        PMID: 22915622     DOI: 10.1136/annrheumdis-2012-201945

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

Review 1.  Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria.

Authors:  Fabian Proft; Denis Poddubnyy
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-05-17       Impact factor: 5.346

Review 2.  Understanding the paradigm of non-radiographic axial spondyloarthritis.

Authors:  Diego Benavent; Victoria Navarro-Compán
Journal:  Clin Rheumatol       Date:  2020-09-29       Impact factor: 2.980

3.  Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis.

Authors:  Mi Ryoung Seo; Hae Lim Baek; Hyun Hwa Yoon; Hee Jung Ryu; Hyo-Jin Choi; Han Joo Baek; Kwang-Pil Ko
Journal:  Clin Rheumatol       Date:  2014-09-05       Impact factor: 2.980

Review 4.  Epidemiology of spondyloarthritis: a review.

Authors:  Gunnstein Bakland; Hans C Nossent
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

Review 5.  The changing clinical picture and epidemiology of spondyloarthritis.

Authors:  Astrid van Tubergen
Journal:  Nat Rev Rheumatol       Date:  2014-11-11       Impact factor: 20.543

Review 6.  Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?

Authors:  Andrew Keat; Alexander N Bennett; Karl Gaffney; Helena Marzo-Ortega; Raj Sengupta; Tamara Everiss
Journal:  Rheumatol Int       Date:  2016-12-29       Impact factor: 2.631

7.  Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland.

Authors:  Rebekah H Borse; Sumesh Kachroo; Chloe Brown; Eilish McCann; Ralph P Insinga
Journal:  Rheumatol Ther       Date:  2018-04-09

8.  Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria.

Authors:  Pascal Zufferey; Jacqueline Ghosn; Fabio Becce; Adrian Ciurea; Bérengère Aubry-Rozier; Axel Finckh; Alexander K So
Journal:  Rheumatol Int       Date:  2014-07-29       Impact factor: 2.631

9.  Evaluation of the early cervical structural change in patients with non-radiographic axial spondyloarthropathy.

Authors:  Melike Cengiz; Şebnem Ataman; İsmihan Sunar; Ayşe Peyman Yalçın; Gürkan Yılmaz; Atilla Halil Elhan
Journal:  Rheumatol Int       Date:  2021-03-06       Impact factor: 2.631

10.  Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1.

Authors:  J Sieper; J Lenaerts; J Wollenhaupt; M Rudwaleit; V I Mazurov; L Myasoutova; S Park; Y Song; R Yao; D Chitkara; N Vastesaeger
Journal:  Ann Rheum Dis       Date:  2013-05-21       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.